A urologic oncology roundtable discussion: the role of disease monitoring in treatment decision-making for patients with metastatic castration-resistant prostate cancer.

Shore ND, Concepcion R, Barocas DA
Hosp Pract (1995). 2013 41 (4): 78-80

PMID: 24145592 · DOI:10.3810/hp.2013.10.1083

MeSH Terms (13)

Androstenols Antineoplastic Agents Cancer Vaccines Decision Making Drug Monitoring Humans Immunotherapy Male Medical Oncology Middle Aged Neoplasm Metastasis Practice Guidelines as Topic Prostatic Neoplasms, Castration-Resistant

Connections (1)

This publication is referenced by other Labnodes entities: